{"title":"ATP结合盒G成员2(ABCG2)转运蛋白在新诊断乳腺癌症辅助化疗患者中基因表达水平的评估","authors":"Shaimaa Soliman","doi":"10.30683/1929-2279.2019.08.04","DOIUrl":null,"url":null,"abstract":": The efficacy of cancer chemotherapy is limited by cellular mechanisms of resistance that result in increased drug efflux of chemotherapeutic agents thereby reducing intracellular drug levels and causing drug resistance. Overexpression of some members of ATP binding cassette transporter superfamily, including ATP binding cassette G member 2 (ABCG2), which mediates energy-dependent transport of drugs out of the cells against concentration gradient, is one of the major mechanisms responsible for multidrug resistance in the treatment of breast cancer. In the current study, the expression of ABCG2 mRNA gene was evaluated in the peripheral blood of newly diagnosed breast cancer (NDBC) patients immediately before surgical resection of the breast and in extirpated breast tumors, then sequentially in the blood of patients after receiving three and six cycles of chemotherapy. Compared to normal breast, cancerous specimens expressed higher levels of ABCG2 gene expression (p<0.001). In addition, a gradual significant increase in the expression of peripheral blood ABCG2 gene of NDBC patients among different treatment periods was recorded. Furthermore, a significant positive correlation between peripheral blood ABCG2 gene expression of NDBC patients receiving chemotherapy and disease progression was found. In conclusion, assessment of ABCG2 gene expression may be a prerequisite in evaluating the effectiveness of chemotherapy-treated breast cancer patients. concentration and purity of total RNA were then assessed by measuring absorbance at 260 and 280 nm, respectively, in a spectrophotometer (Nano Drop 2000, Thermo Scientific, USA). Reverse transcription of the to synthesize first strand complementary DNA (cDNA) performed using AMV Reverse Transcriptase kit (Promega, WI, USA). Real-time PCR amplification and analysis were performed in ABI 7500 Fast Sequence Detection System","PeriodicalId":89799,"journal":{"name":"Journal of cancer research updates","volume":" ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2019-12-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Assessment of Gene Expression Level of ATP Binding Cassette G Member 2 (ABCG2) Transporter in Newly Diagnosed Breast Cancer Patients Receiving Adjuvant Chemotherapy\",\"authors\":\"Shaimaa Soliman\",\"doi\":\"10.30683/1929-2279.2019.08.04\",\"DOIUrl\":null,\"url\":null,\"abstract\":\": The efficacy of cancer chemotherapy is limited by cellular mechanisms of resistance that result in increased drug efflux of chemotherapeutic agents thereby reducing intracellular drug levels and causing drug resistance. Overexpression of some members of ATP binding cassette transporter superfamily, including ATP binding cassette G member 2 (ABCG2), which mediates energy-dependent transport of drugs out of the cells against concentration gradient, is one of the major mechanisms responsible for multidrug resistance in the treatment of breast cancer. In the current study, the expression of ABCG2 mRNA gene was evaluated in the peripheral blood of newly diagnosed breast cancer (NDBC) patients immediately before surgical resection of the breast and in extirpated breast tumors, then sequentially in the blood of patients after receiving three and six cycles of chemotherapy. Compared to normal breast, cancerous specimens expressed higher levels of ABCG2 gene expression (p<0.001). In addition, a gradual significant increase in the expression of peripheral blood ABCG2 gene of NDBC patients among different treatment periods was recorded. Furthermore, a significant positive correlation between peripheral blood ABCG2 gene expression of NDBC patients receiving chemotherapy and disease progression was found. In conclusion, assessment of ABCG2 gene expression may be a prerequisite in evaluating the effectiveness of chemotherapy-treated breast cancer patients. concentration and purity of total RNA were then assessed by measuring absorbance at 260 and 280 nm, respectively, in a spectrophotometer (Nano Drop 2000, Thermo Scientific, USA). Reverse transcription of the to synthesize first strand complementary DNA (cDNA) performed using AMV Reverse Transcriptase kit (Promega, WI, USA). Real-time PCR amplification and analysis were performed in ABI 7500 Fast Sequence Detection System\",\"PeriodicalId\":89799,\"journal\":{\"name\":\"Journal of cancer research updates\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2019-12-25\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of cancer research updates\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.30683/1929-2279.2019.08.04\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of cancer research updates","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.30683/1929-2279.2019.08.04","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
摘要
:癌症化疗的疗效受到细胞耐药机制的限制,细胞耐药机制导致化疗药物流出增加,从而降低细胞内药物水平并引起耐药性。ATP结合盒转运蛋白超家族的一些成员的过表达,包括ATP结合盒G成员2(ABCG2),其介导能量依赖性药物逆浓度梯度转运出细胞,是导致癌症治疗中多药耐药性的主要机制之一。在目前的研究中,在新诊断的癌症(NDBC)患者的外周血中以及在切除的乳腺肿瘤中评估了ABCG2 mRNA基因的表达,然后在接受三个和六个周期的化疗后依次在患者的血液中评估。与正常乳腺相比,癌组织中ABCG2基因表达水平较高(p<0.001)。此外,NDBC患者外周血ABCG2基因的表达在不同治疗期间逐渐显著增加。此外,接受化疗的NDBC患者外周血ABCG2基因表达与疾病进展呈显著正相关。总之,评估ABCG2基因表达可能是评估癌症患者化疗效果的先决条件。然后通过在分光光度计(Nano Drop 2000,Thermo Scientific,USA)中分别测量260和280nm处的吸光度来评估总RNA的浓度和纯度。使用AMV逆转录酶试剂盒(Promega,WI,USA)进行逆转录以合成第一链互补DNA(cDNA)。在ABI 7500快速序列检测系统中进行实时PCR扩增和分析
Assessment of Gene Expression Level of ATP Binding Cassette G Member 2 (ABCG2) Transporter in Newly Diagnosed Breast Cancer Patients Receiving Adjuvant Chemotherapy
: The efficacy of cancer chemotherapy is limited by cellular mechanisms of resistance that result in increased drug efflux of chemotherapeutic agents thereby reducing intracellular drug levels and causing drug resistance. Overexpression of some members of ATP binding cassette transporter superfamily, including ATP binding cassette G member 2 (ABCG2), which mediates energy-dependent transport of drugs out of the cells against concentration gradient, is one of the major mechanisms responsible for multidrug resistance in the treatment of breast cancer. In the current study, the expression of ABCG2 mRNA gene was evaluated in the peripheral blood of newly diagnosed breast cancer (NDBC) patients immediately before surgical resection of the breast and in extirpated breast tumors, then sequentially in the blood of patients after receiving three and six cycles of chemotherapy. Compared to normal breast, cancerous specimens expressed higher levels of ABCG2 gene expression (p<0.001). In addition, a gradual significant increase in the expression of peripheral blood ABCG2 gene of NDBC patients among different treatment periods was recorded. Furthermore, a significant positive correlation between peripheral blood ABCG2 gene expression of NDBC patients receiving chemotherapy and disease progression was found. In conclusion, assessment of ABCG2 gene expression may be a prerequisite in evaluating the effectiveness of chemotherapy-treated breast cancer patients. concentration and purity of total RNA were then assessed by measuring absorbance at 260 and 280 nm, respectively, in a spectrophotometer (Nano Drop 2000, Thermo Scientific, USA). Reverse transcription of the to synthesize first strand complementary DNA (cDNA) performed using AMV Reverse Transcriptase kit (Promega, WI, USA). Real-time PCR amplification and analysis were performed in ABI 7500 Fast Sequence Detection System